Titre original:
« Long term observational, prospective study to collect in a real-life setting data on the retention, effectiveness, safety, treatment pattern, quality of life (QoL), and efficiency of secukinumab in adult patients with moderate to severe plaque psoriasis. ».
Indication (pathologie):
Psoriasis
Identifiant SNOMED-CT:
SNOMEDCT/9014002
Identifiant EUDRA-CT:
P2016/369 / B143201629349
Recrutement:
Fermé
Service:
Investigateur principal:
del Marmol Véronique
Sponsor:
Novartis
Tél contact:
02 555 46 12
Email contact:
Adresse hôpital:
Cliniques Universitaires de Bruxelles Hôpital Erasme
Route de Lennik 808,1070 Bruxelles, Belgique